RSS Feed ALL Johnson & Johnson en-us Fri, 09 Aug 2019 20:53:33 GMT 22 23 0 1 2 3 4 5 60 Janssen Announces U.S. FDA Accelerated Approval for SIRTURO? (bedaquiline) as Part of Combination Therapy to Treat Adolescents with Pulmonary Multidrug-Resistant Tuberculosis Fri, 09 Aug 2019 20:53:33 GMT Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference Thu, 08 Aug 2019 18:47:59 GMT Johnson & Johnson to Participate in the Wells Fargo Securities 2019 Healthcare Conference Thu, 08 Aug 2019 18:41:39 GMT Janssen reports positive top-line Phase 3 results for ponesimod in adults with relapsing multiple sclerosis Thu, 25 Jul 2019 20:28:27 GMT Johnson & Johnson Announces New Clinical Data on Mosaic-based HIV Preventive Vaccine Regimen Tue, 23 Jul 2019 15:00:24 GMT Johnson & Johnson Establishes International Consortium to Advance Pioneering Science in the Fight to End Tuberculosis Tue, 23 Jul 2019 12:28:41 GMT Johnson & Johnson Reports 2019 Second-Quarter Results: Tue, 16 Jul 2019 10:40:37 GMT Johnson & Johnson Extends Long-Standing Donation Program to Support Global Effort to Tackle Intestinal Worms Tue, 16 Jul 2019 07:00:32 GMT Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2019 Mon, 15 Jul 2019 15:01:27 GMT Johnson & Johnson Announces New Public-Private Partnership to Support First Phase 3 Efficacy Study of Janssen’s Investigational Prophylactic HIV Vaccine Mon, 15 Jul 2019 14:10:00 GMT Janssen Submits Application to U.S. FDA Seeking Approval of New DARZALEX? (daratumumab) Subcutaneous Formulation Fri, 12 Jul 2019 16:42:03 GMT XARELTO? (rivaroxaban) Helps Protect Pediatric Patients from Blood Clots in Late-Breaking Phase 3 EINSTEIN-Jr Study Mon, 08 Jul 2019 13:48:30 GMT Janssen Announces U.S. FDA Approval of DARZALEX? (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible Thu, 27 Jun 2019 18:50:30 GMT Janssen Announces Collaboration with University of California, Berkeley and University of California, San Francisco to Expand Data Science Research in Healthcare Fri, 21 Jun 2019 17:01:27 GMT Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results Tue, 18 Jun 2019 11:47:47 GMT Janssen reports top-line Phase 3 results for TREMFYA? (guselkumab) in adults with active psoriatic arthritis Fri, 14 Jun 2019 14:34:03 GMT INVOKANA? (canagliflozin) Significantly Reduced Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in New CREDENCE Analysis Tue, 11 Jun 2019 17:12:06 GMT Johnson & Johnson Releases 2018 Health for Humanity Report Wed, 05 Jun 2019 13:39:46 GMT IMBRUVICA? (ibrutinib) Long-Term Data from Two Pivotal Phase 3 Studies at ASCO and EHA Demonstrate Sustained Efficacy and Safety in Patients with Chronic Lymphocytic Leukemia (CLL) Mon, 03 Jun 2019 14:25:37 GMT DARZALEX? (daratumumab) Investigational Study Shows Increased Depth of Response and Longer Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Eligible for a Transplant Mon, 03 Jun 2019 14:21:39 GMT Phase 3 COLUMBA Study Investigating a Subcutaneous Formulation of DARZALEX? (daratumumab) Showed Non-Inferiority to Intravenous Administration in Patients with Relapsed/Refractory Multiple Myeloma Mon, 03 Jun 2019 14:17:31 GMT ERLEADA? (apalutamide) Significantly Improved Overall Survival (OS) and Radiographic Progression-Free Survival (rPFS) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Fri, 31 May 2019 22:32:16 GMT DARZALEX? (daratumumab) Phase 3 MAIA Study Results Published in The New England Journal of Medicine Show Combination Therapy Increases Progression-Free Survival in Newly Diagnosed Patients with Multiple Myeloma Who are Transplant Ineligible Wed, 29 May 2019 22:23:55 GMT Johnson & Johnson Announces Full Enrollment in Proof-of-Concept Efficacy Study of Janssen’s Investigational HIV Preventive Vaccine Wed, 29 May 2019 10:01:26 GMT New Data Highlights the Value of SPRAVATO? (esketamine) CIII Nasal Spray, the First New Antidepressant in Decades that Works Differently for Adults with Treatment-Resistant Depression (TRD)[1] Wed, 22 May 2019 13:55:01 GMT 免费黄片